title: Decrease in autoantibody titres during long-term treatment of scleroderma with rituximab: a promising surveillance marker of therapy?
authors.affiliation: a Departments of Rheumatology and Immunology , Medical University Graz , Austria.
authors.forename: F C
authors.initials: FC
authors.lastname: Moazedi-Fuerst
authors.affiliation: a Departments of Rheumatology and Immunology , Medical University Graz , Austria.
authors.forename: S M
authors.initials: SM
authors.lastname: Kielhauser
authors.affiliation: a Departments of Rheumatology and Immunology , Medical University Graz , Austria.
authors.forename: J
authors.initials: J
authors.lastname: Hermann
authors.affiliation: b Departments of Pulmonology , Medical University Graz , Austria.
authors.forename: M
authors.initials: M
authors.lastname: Meilinger
authors.affiliation: a Departments of Rheumatology and Immunology , Medical University Graz , Austria.
authors.forename: U
authors.initials: U
authors.lastname: Demel
authors.affiliation: a Departments of Rheumatology and Immunology , Medical University Graz , Austria.
authors.forename: M H
authors.initials: MH
authors.lastname: Stradner
authors.affiliation: a Departments of Rheumatology and Immunology , Medical University Graz , Austria.
authors.forename: W B
authors.initials: WB
authors.lastname: Graninger
mesh_terms: D000974:Antibodies, Antinuclear / Q000097:blood / Q000276:immunology; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001323:Autoantibodies / Q000097:blood* / Q000276:immunology; D015415:Biomarkers / Q000097:blood; D004264:DNA Topoisomerases, Type I / Q000097:blood / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007157:Immunologic Surveillance; D000069283:Rituximab / Q000627:therapeutic use*; D045743:Scleroderma, Diffuse / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D012680:Sensitivity and Specificity; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000974:Antibodies, Antinuclear; D018501:Antirheumatic Agents; D001323:Autoantibodies; D015415:Biomarkers; D000069283:Rituximab; D004264:DNA Topoisomerases, Type I